About this trial
Some people experience chest pain and shortness of breath, but when they have tests, no blockages are found in their main heart arteries. The most common cause of symptoms is related to abnormalities in the small blood vessels, also known as 'small vessel angina' or Coronary Microvascular Dysfunction (CMD). Currently, the diagnosis of CMD requires additional measurements of blood flow in the heart vessel during a minimally invasive procedure known as a coronary angiogram.
CMD affects many people and can lead to repeated hospital visits and a lower quality of life, and diagnosing the condition leads to better patient outcomes. However, there are still no widely available, proven treatments for this condition and therefore several patients remain symptomatic.
This study aims to find better ways to treat CMD, especially by understanding how the heart uses energy and how this might relate to symptoms.
Eligibility criteria
Qualifiers
Angina with non-obstructive coronary arteries
Disqualifiers
Significant epicardial coronary stenoses
Inability to carry out bike exercise
Contra-indication to adenosine administration
Insulin usage with frequent hypoglycaemic episodes
Trial design
Treatments tested in this trial
- Empagliflozin 10mg OD
Treatment groups
Locations
Sponsors and collaborators
King's College London
Lead sponsor
Guy's and St Thomas' NHS Foundation Trust
Collaborator